PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • These technologies are being developed by several companies including Alnylam Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc., Genzyme (a Sanofi Company) and Regulus Therapeutics, LLC. We expect to face intense competition from other companies for collaborative arrangements with pharmaceutical and biotechnology companies; for
http://www.w3.org/ns/prov#wasQuotedFrom
  • sec.gov